Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABP-745 for acute gouty arthritis
CTR20253264Phase 2Active
- Sponsor
- Jiangsu Atom Bioscience & Pharmaceutical Co., Ltd.
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ABP-745 in gout, sponsored by Jiangsu Atom Bioscience & Pharmaceutical Co., Ltd.. Started Aug 2025; status: active.
02
Drugs
ABP-745
03
Conditions
gout
Beyond the preview
Go deeper on CTR20253264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253264.